Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants

Anne Gulbech Ording; Mette Søgaard; Flemming Skjøth; Erik Lerkevang Grove; Professor Gregory Lip; Torben Bjerregaard Larsen; Peter Brønnum Nielsen

doi:10.1002/cam4.4012

Back

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants

Article 2021 en

Abstract

1 min read

Evidence from this nationwide cohort study suggests a comparable 1-year risk of bleeding associated with DOAC compared with VKA among patients with AF and GI cancer.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2023

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Tze‐Fan Chao, Ling Kuo, Professor Gregory Lip, S A Chen

Article2021

Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer

Daniele Pastori, A Marang, Arnaud Bisson, Julien Herbert, Professor Gregory Lip, Laurent Fauchier

Article2019

P4780Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease

Inki Moon, S R Lee, Eunsuk Choi, E J Lee, Jin‐Hyung Jung, Kyungdo Han, M J, Seil Oh, Professor Gregory Lip

Preprint2020

Effectiveness, Safety, and Major Adverse Limb Events in Atrial Fibrillation Patients with Concomitant Diabetes Mellitus Treated with Non-Vitamin K Antagonist Oral Anticoagulants

Yi‐Hsin Chan, Hsin‐Fu Lee, Pei‐Ru Li, Jia‐Rou Liu, Tze‐Fan Chao, Lung‐Sheng Wu, Shang‐Hung Chang, Yung‐Hsin Yeh, Chi‐Tai Kuo, Lai‐Chu See, Professor Gregory Lip